Table of Contents
A CDSCO inspection is one of the most consequential events in a Medical Device company’s regulatory journey in India. Whether you are a manufacturer or Importer, demonstrating compliance with the Medical Devices Rules (MDR), 2017 is essential for obtaining and maintaining regulatory approvals.
For manufacturing license applicants, a successful inspection is a prerequisite for license grant. For licensed manufacturers, periodic inspections determine whether the license is renewed, suspended, or cancelled. For importers, site audits of foreign manufacturing facilities are increasingly a part of Class C and D import license review.
Yet many companies — particularly those new to the Indian regulatory environment — arrive at inspections underprepared. This article provides a comprehensive, actionable guide to CDSCO inspection readiness.
CDSCO and State Licensing Authorities (SLAs) conduct inspections in a range of circumstances:
Foreign Manufacturing Site Assessment: For certain Class C and Class D Medical Device import applications, CDSCO may evaluate the foreign manufacturing facility through a review of submitted documentation such as the Plant Master File (PMF), Quality Management System certificates, regulatory approvals, audit reports, and technical documentation. Where deemed necessary based on risk, product classification, or regulatory concerns, CDSCO may also conduct an on-site inspection of the overseas manufacturing facility.
CDSCO inspections of Medical Device manufacturing facilities are structured around Schedule V of MDR 2017, which sets out the requirements for manufacturing premises and quality systems. Inspectors assess compliance across the following key domains:
| Inspection Domain | Key Focus Areas |
| Premises and facilities | Facility layout, segregation of manufacturing areas, environmental controls, cleanroom standards where applicable, pest control, utilities |
| Equipment and calibration | Equipment list, calibration records, preventive maintenance schedules, validation status of critical equipment |
| Personnel and training | Qualifications of Responsible Technical Person (RTP), training records for all production and QC staff, SOPs for key roles |
| Quality Management System | QMS documentation, document control system, internal audit records, management review minutes, CAPA system |
| Manufacturing and process controls | Batch manufacturing records, in-process inspection records, deviation management, process validation data |
| Incoming inspection and supplier control | Incoming raw material inspection procedures, approved supplier list, Certificate of Analysis review records |
| Product testing and QC | Test procedures, laboratory equipment and calibration, out-of-specification investigation records, batch release procedures |
| Sterilisation (where applicable) | Sterilisation cycle records, biological indicator results, environmental monitoring records, parametric release procedures, and periodic revalidation reports. |
| Post-market surveillance | Complaint handling system, adverse event reporting procedures, product recall procedures, post-market surveillance plan |
| Labelling and packaging control | Label reconciliation, label approval procedures, finished product inspection records |
| Risk management | Risk management file, hazard analysis, risk-benefit evaluation, post-market risk review, alignment with ISO 14971 |
Table 1
Product and Manufacturing Documentation
Documentation alone does not make a site inspection-ready. Physical site conditions are assessed with equal rigour. Before the inspection date:
A very common and avoidable inspection finding is that the Quality Manual and SOPs describe a QMS that is not actually being implemented in practice. Inspectors are trained to look for this gap — and it results in major observations that can delay or jeopardise license grant.
Following the inspection, CDSCO or the SLA will issue an inspection report listing any observations.Observations are typically categorized according to their significance (for example, major or minor observations), depending on the inspection authority’s assessment.
The typical response process is:
Repeated or unresolved major observations can result in license suspension or refusal. Companies that respond to observations with thorough, evidence-backed CAPAs consistently achieve faster resolution.
Parametric Release is a sterility assurance approach where a sterilized product is released for distribution based on demonstrated compliance with critical sterilization process parameters, rather than relying solely on end-product sterility testing.
Instead of testing the finished device to see whether it is sterile, the manufacturer proves that:
If all parameters are met, the batch can be released.
A CDSCO inspection is not something to prepare for in the weeks immediately before it is scheduled. Inspection readiness is a function of the quality systems, documentation discipline, and site management practices that a company builds and maintains every day. Companies that embed compliance into their operations — not just their paper systems — consistently pass inspections and receive licenses on time.
Traditional Medical Device regulation assumes a fixed product: what’s approved is what ships, indefinitely, until a formal change is filed and reviewed. Adaptive AI and machine learning algorithms b..
Getting a Cosmetic product registered and onto shelves in India is only half the job. Once a product is in the market, the Cosmetics Rules, 2020 place ongoing duties on manufacturers and Importers to ..
Although software intended for Medical purposes has been regulated in India since the implementation of MDR, 2017 Rules. CDSCO’s Guidance Document on Medical Device Software (Doc No. CDSCO/MD/GD..
India
Global
Sales: +91 7672005050
Reception: +91-11-45214546
9 am to 6 pm (Monday to Friday)